Evaluating β-amyloidosis progression in Alzheimer's disease with Mueller polarimetry

Mariia Borovkova1,2, Alexander Bykov1, Alexey Popov3

  • 1Optoelectronics and Measurement Techniques, University of Oulu, 90570 Oulu, Finland.

Biomedical Optics Express
|September 14, 2020
PubMed

Insights

Wide-field Mueller imaging polarimetry detects amyloid-beta (Aβ) plaques in Alzheimer

Area of Science:

  • Neuroscience and Biomedical Optics
  • Pathology and Medical Imaging

Background:

  • Alzheimer's disease (AD) is characterized by the accumulation of amyloid-beta (Aβ) deposits in the brain.
  • Current histopathology screening for Aβ plaques can be time-consuming and costly.

Purpose of the Study:

  • To investigate the utility of wide-field Mueller imaging polarimetry for label-free screening of Aβ plaques in mouse brain tissue.
  • To determine if polarimetric properties correlate with the progression of Aβ deposition in Alzheimer's disease models.

Main Methods:

  • Application of multi-spectral Mueller imaging polarimetry to formalin-fixed paraffin-embedded mouse brain tissue.
  • Analysis of the degree of depolarization and higher-order statistical moments of the backscattered polarized light.
  • Statistical correlation between polarimetric measurements and the presence/extent of Aβ plaques.

Main Results:

  • Amyloid-beta plaques significantly alter the depolarization properties of backscattered polarized light.
  • High-order statistical moments of depolarization distributions serve as sensitive markers for Aβ plaque presence.
  • A clear correlation was observed between polarimetric data and the progression of brain β-amyloidosis.

Conclusions:

  • Label-free Mueller imaging polarimetry effectively detects and quantifies Aβ plaques in Alzheimer's disease models.
  • This polarimetric approach shows potential for improving the accuracy, speed, and cost-efficiency of histopathological screening for AD.

Related Concept Videos